Identification of cell surface and secreted proteins essential for tumor cell survival using a genetic suppressor element screen (Q31111319)

28 June 2017

Identification of cell surface and secreted proteins essential for tumor cell survival using a genetic suppressor element screen (English)

1 reference

28 June 2017

Marina S Gelman

1

1 reference

28 June 2017

X Katherine Ye

2

1 reference

28 June 2017

Robert Stull

3

1 reference

28 June 2017

David Suhy

4

1 reference

28 June 2017

Liang Jin

5

1 reference

28 June 2017

Dean Ng

6

1 reference

28 June 2017

Bruce Than

7

1 reference

28 June 2017

May Ji

8

1 reference

28 June 2017

Alison Pan

9

1 reference

28 June 2017

Paul Perez

10

1 reference

28 June 2017

Yan Sun

11

1 reference

28 June 2017

Patricia Yeung

12

1 reference

28 June 2017

Luz Maria Garcia

13

1 reference

28 June 2017

Rachel Harte

14

1 reference

28 June 2017

Yan Lu

15

1 reference

28 June 2017

Elizabeth Lamar

16

1 reference

28 June 2017

Roya Tavassoli

17

1 reference

28 June 2017

Scot Kennedy

18

1 reference

28 June 2017

Stephen Osborn

19

1 reference

28 June 2017

Daniel J Chin

20

1 reference

28 June 2017

Kay Meshaw

21

1 reference

28 June 2017

Tatyana A Holzmayer

22

1 reference

28 June 2017

Sergey A Axenovich

23

1 reference

28 June 2017

Arie Abo

24

1 reference

28 June 2017

language of work or name

English

0 references

publication date

1 October 2004

1 reference

28 June 2017

1 reference

28 June 2017

23

1 reference

28 June 2017

8158-8170

1 reference

28 June 2017

49

1 reference

The mechanism of tumor cell clearance by rituximab in vivo in patients with B-cell chronic lymphocytic leukemia: evidence of caspase activation and apoptosis induction

28 June 2017

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208054

Transdominant genetic analysis of a growth control pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208054

Improving the efficacy of antibody-based cancer therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208054

Inducible retroviral vectors regulated by lac repressor in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208054

Decreased expression of the mannose 6-phosphate/insulin-like growth factor-II receptor promotes growth of human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208054

Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208054

Isolation of efficient antivirals: genetic suppressor elements against HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208054

Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208054

RNA interference is mediated by 21- and 22-nucleotide RNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208054

Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208054

Identification of p53 genetic suppressor elements which confer resistance to cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208054

The candidate tumour suppressor p33ING1 cooperates with p53 in cell growth control

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208054

A simple and very efficient method for generating cDNA libraries

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208054

Cloning mammalian genes by expression selection of genetic suppressor elements: association of kinesin with drug resistance and cell immortalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208054

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208054

Isolation of dominant negative mutants and inhibitory antisense RNA sequences by expression selection of random DNA fragments

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208054

Expression profiling reveals off-target gene regulation by RNAi

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208054

M6P/IGF2R loss of heterozygosity in head and neck cancer associated with poor patient prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208054

Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU)/leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208054

Continuous cultures of fused cells secreting antibody of predefined specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208054

M6P/IGF2R is mutated in squamous cell carcinoma of the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208054

Mannose 6-phosphate/insulin-like growth factor II receptor is a death receptor for granzyme B during cytotoxic T cell-induced apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208054

Molecular cloning of Lyt-2, a membrane glycoprotein marking a subset of mouse T lymphocytes: molecular homology to its human counterpart, Leu-2/T8, and to immunoglobulin variable regions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208054

Dominant negative form of signal-regulatory protein-alpha (SIRPalpha /SHPS-1) inhibits tumor necrosis factor-mediated apoptosis by activation of NF-kappa B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208054

Identification of potential anticancer drug targets through the selection of growth-inhibitory genetic suppressor elements

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208054

Opposing roles for the insulin-like growth factor (IGF)-II and mannose 6-phosphate (Man-6-P) binding activities of the IGF-II/Man-6-P receptor in the growth of prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208054

Expression of the wild-type insulin-like growth factor II receptor gene suppresses growth and causes death in colorectal carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208054

Use of isogenic human cancer cells for high-throughput screening and drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208054

Loss of the gene encoding mannose 6-phosphate/insulin-like growth factor II receptor is an early event in liver carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208054

Cation-independent mannose 6-phosphate receptor blocks apoptosis induced by herpes simplex virus 1 mutants lacking glycoprotein D and is likely the target of antiapoptotic activity of the glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208054

21 January 2018

Identifiers

DOI

10.1038/SJ.ONC.1208054

1 reference

Dimensions Publication ID

28 June 2017

0 references

1 reference